Collplant Biotechnologies Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Collplant Biotechnologies Stock Summary

Collplant Biotechnologies competes with Keros Therapeutics, Merus BV, Vericel Corp, Century Therapeutics, and Shattuck Labs. CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. CollPlant Biotechnologies Ltd. was founded in 2004 and is headquartered in Rehovot, Israel. CollPlant Biotechnologies operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 66 people.

Collplant Biotechnologies Key Financial Ratios

Collplant Biotechnologies Key Balance Sheet Accounts

Collplant Biotechnologies Key Income Statement Accounts

Collplant Biotechnologies Key Cash Accounts

Collplant Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Collplant Biotechnologies's current stock value. Our valuation model uses many indicators to compare Collplant Biotechnologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Collplant Biotechnologies competition to find correlations between indicators driving Collplant Biotechnologies's intrinsic value. More Info.Collplant Biotechnologies is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Collplant Biotechnologies' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Collplant Biotechnologies' earnings, one of the primary drivers of an investment's value.

Collplant Biotechnologies' Earnings Breakdown by Geography

Collplant Biotechnologies Systematic Risk

Today, most investors in Collplant Biotechnologies Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Collplant Biotechnologies' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Collplant Biotechnologies growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Collplant Biotechnologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Collplant Biotechnologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Collplant Biotechnologies based on widely used predictive technical indicators. In general, we focus on analyzing Collplant Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Collplant Biotechnologies's daily price indicators and compare them against related drivers.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Collplant Biotechnologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collplant Biotechnologies. If investors know Collplant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collplant Biotechnologies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Collplant Biotechnologies is measured differently than its book value, which is the value of Collplant that is recorded on the company's balance sheet. Investors also form their own opinion of Collplant Biotechnologies' value that differs from its market value or its book value, called intrinsic value, which is Collplant Biotechnologies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collplant Biotechnologies' market value can be influenced by many factors that don't directly affect Collplant Biotechnologies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Collplant Biotechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Collplant Biotechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collplant Biotechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.